Precigen is a commercial-stage biopharmaceutical company focused on urgently delivering highly targeted precision medicines to address difficult-to-treat diseases with high unmet patient need. The company advances precision immunology through novel multifunctional gene and cell therapies designed for immuno-oncology, autoimmune disorders, and infectious diseases.
Tip: The CEO isn't always your best path in. Data Surfer finds the champions and influencers who actually drive purchasing decisions.
| Ownership Public Company |
| Stock PGEN (NASDAQ) |
Precigen is a commercial-stage biopharmaceutical company that develops next-generation gene and cell therapies for immuno-oncology, autoimmune disorders, and infectious diseases.
Precigen operates as a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of precision medicines and gene therapies.
Get qualified leads in 10 minutes. Research prospects, find decision makers, and monitor for the perfect moment to reach out.
Last verified: February 2, 2026
Connect with Precigen